CDH1 and endometrium adenocarcinoma: Melatonin has been found to inhibit 17β-estradiol (E2)-induced proliferation, invasion, and EMT in endometrial adenocarcinoma cells by upregulating NUMB and E-cadherin, indicating a potential role for NUMB-targeting hormonal therapies [20].